Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2001
11/15/2001WO2001085689A1 Piperidine compounds and process for providing such
11/15/2001WO2001085675A2 Fluorous tagging compounds and their use
11/15/2001WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/15/2001US20010041797 Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties
11/15/2001US20010041735 Amino ceramide - like compounds and therapeutic methods of use
11/15/2001US20010041714 Serotonin-7 (5-HT7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/15/2001US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001US20010041674 Reacting a acetophenyl derivative with an aromatic aldehyde or heterocylic containing aldehyde derivative by aldol condentation followed by reduction
11/15/2001DE19954230A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease
11/15/2001DE10023430A1 New N-benzoyl-N'-(tetrazolyl-phenyl)-urea derivatives, useful as pesticides e.g. insecticides, acaricides, nematocides, ectoparasiticides, antifouling agents, herbicides, fungicides and bactericides
11/15/2001DE10023085A1 Arylamino and aralkylamino substituted quinoline and quinazoline derivatives, useful for the treatment of e.g. tumors, pulmonary, respiratory and gastrointestinal disorders and psoriasis
11/15/2001CA2409729A1 5-ht7 receptor antagonists
11/15/2001CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001CA2408343A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001CA2408095A1 Fluorous tagging compounds and their use
11/15/2001CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP1153919A1 Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active beta3 agonist by the use of the same
11/14/2001EP1153100A1 Photochromatic compounds, process for their preparation and their use in polymeric materials
11/14/2001EP1153050A1 Amino-ketone solid support templates
11/14/2001EP1153023A1 Process for the production of paroxetine
11/14/2001EP1153022A1 Prothease inhibitors
11/14/2001EP1153013A2 5-ht1f agonists
11/14/2001EP1021437B1 Arylsulfonylimidazolone derivatives as an antitumor agent
11/14/2001EP0801700B1 Use of optically brightened plastics for optically brightening paper-coating compounds and paper-coating compounds optically brightened in this manner
11/14/2001CN1322202A Quinazoline derivatives
11/14/2001CN1322133A Vitronectin receptor antagonists
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/13/2001US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors
11/13/2001US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/08/2001WO2001083800A2 Heterologous production of polyketides
11/08/2001WO2001083476A1 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/08/2001WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001WO2001083474A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
11/08/2001WO2001083472A1 Muscarinic agonists
11/08/2001WO2001083470A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/08/2001WO2001083469A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001WO2001029012A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001WO2001029011A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001US20010039341 Biphenyl-Substituted Triazines
11/08/2001US20010039290 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
11/08/2001US20010039287 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/08/2001US20010039286 Especially substance P
11/08/2001US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001US20010039281 No drug resistance; intravenous
11/08/2001US20010039271 For treatment of male erectile dysfunction, female sexual dysfunction
11/08/2001CA2407796A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001CA2407594A1 Muscarinic agonists
11/08/2001CA2407535A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/08/2001CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001CA2405614A1 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/08/2001CA2405607A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
11/07/2001EP1150980A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
11/07/2001EP1150958A1 Substituted pyrazole carboxylic acids used to combat anaemias
11/07/2001EP1150955A2 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
11/07/2001EP1150954A1 Anti-imflammatory indole derivatives
11/07/2001EP1150746A2 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
11/07/2001EP1150676A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
11/07/2001EP1070061A4 Oxidation process using periodic acid
11/07/2001EP1066282B1 Novel cationic di-methylenedioxy-benzenes, their use for oxidation dyeing of keratin fibres
11/07/2001EP0871626B1 triazolones as apolipoprotein-b synthesis inhibitors
11/07/2001EP0861235B1 Substituted benzylaminopiperidine compounds
11/07/2001EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
11/07/2001EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001EP0546108B1 Pro-drugs for cck antagonists
11/07/2001CN1321155A Process for preparation of non-crystalline anhydrate form of paroxetine hydrochloride
11/07/2001CN1321151A Chemical compounds
11/07/2001CN1320596A Process for preparing substd. pyridines compounds
11/07/2001CN1320375A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1320374A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1320373A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1074414C indolylalkyl derivs. of benzodioxanmethylamine as 5-HT1A receptor ligands
11/07/2001CN1074412C Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivs. and medicines contg. same as active ingredient
11/06/2001US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001US6313310 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
11/06/2001US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313294 Solvent-free amidation reaction of molten secondary alkylenediamine and ester to form tertiary amide; one step; noncatalytic reaction
11/06/2001US6313293 Preparation of amides and quinazoline derivatives
11/06/2001US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001US6313126 For threrapy of disorders associated with dysfunction in serotonergic neurotransmission, including depression and anxiety
11/06/2001US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001CA2193178C Matrix metalloprotease inhibitors
11/03/2001CA2345760A1 Pharmaceutical uses for fluoroalkoxybenzylamino and alkoxybenzylamino derivatives of nitrogen containing heterocycles
11/01/2001WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001WO2001081338A1 Substituted sulfonylaminopyrimidines
11/01/2001WO2001081335A1 Pyrimidine-sulfonamides having endothelin-antagonist activity
11/01/2001WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
11/01/2001WO2001081318A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001WO2001081314A1 Naphthamidine urokinase inhibitors
1 ... 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 ... 694